-
CYP2C8-Mediated Drug–Drug Interactions and the Factors Influencing the Interaction Magnitude
16 Sep 2025 09:22 GMT
… CYP2C8 inhibitor whereas prasugrel does not demonstrate … to comedicate with statins.85
Antidepressants
Fluvoxamine is commonly … and clinical pharmaceutical care. Develop new drugs that are … CYP2C8 perpetrators (dose, treatment course, systemic concentrations, …
-
Trial compares the use of blood thinners after stenting in patients with acute coronary syndromes
03 Sep 2025 19:50 GMT
… New England Journal of Medicine.
DAPT consisting of aspirin … randomized controlled NEO-MINDSET trial was conducted across 50 … undergoing successful PCI with drug-eluting stents were randomized … inhibitor monotherapy (ticagrelor or prasugrel) or to DAPT (aspirin …
-
The heart attack-preventing drug that could steal aspirin’s crown
01 Sep 2025 16:33 GMT
… dose form as a treatment for cardiovascular problems such … .
Researchers analysing clinical trials involving nearly 30,000 … medicine only if advised to do so by your doctor. … platelet.
Other antiplatelet drugs include ticagrelor, prasugrel and dipyridamole. For …
-
Association Between ABCB1 Gene Polymorphism with Hyperglycemia and MACE in Patients Undergoing Clopidogrel Treatment After PCI
25 Aug 2025 07:43 GMT
… Pharmacy, Taian Public Health Medical Centre, Taian, Shandong … hypertension, patient compliance, drug interactions, and genetic … inhibition for optimal drug delivery. Drug Target Insights. … treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial …
-
Colchicine and Drug-Drug Interactions in ASCVD
14 Aug 2025 16:00 GMT
… drug-drug interactions (DDIs) with mainstay cardiovascular medications, such as statins … (e.g., clopidogrel, prasugrel, ticagrelor) used to prevent … multiple randomized, controlled trials, and findings are … COLIN trial: value of colchicine in the treatment of …
-
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025 10:49 GMT
… /Late-Breaking Trials: Major Late-Breaking Trials from EuroPCR 2025
Presentation … followed by dose reduction of prasugrel after drug-coated stent insertion in … Research
Randomized controlled/clinical trial
Subject of Research
People
Article …
-
Advances in the Clinical Use of Clopidogrel: A Review of Individualized Treatment Strategies and Monitoring Optimization Based on Genetic Polymorphisms
09 Jul 2025 13:50 GMT
… . As the precision medicine paradigm advances, dynamic … US Food and Drug Administration (FDA) recommended that individuals … in randomized clinical trials and registration experience, … treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial …
-
Artery Stenosis Drug Market Report 2025: For Strategy Officers and Market Intelligence Teams
16 Jun 2025 12:07 GMT
… Pharmaceuticals.
What Are The Emerging Trends In The Artery Stenosis Drug … address unmet medical needs in the treatment of … Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole
2 By … Anticoagulants DOACs
3 By Statins: Atorvastatin, Simvastatin, …
-
Early switch to prasugrel monotherapy safe in ACS stenting patients: study
27 May 2025 07:11 GMT
… coronary syndrome (ACS) to prasugrel monotherapy after one month of … year.
Gachon University Gil Medical Center announced Tuesday that the … prasugrel monotherapy at a reduced dose: the 4D-ACS randomized trial … Top 3 Late Breaking Trials at the 2025 European …
-
What to know about medications for coronary artery disease
23 May 2025 15:13 GMT
… and prasugrel are medications … statins
Non-statins are cholesterol-lowering medications that doctors may prescribe in addition to statins … doctor about possible drug-drug interactions, especially if they are taking other medications. A doctor … The treatment for …